United States Smithtown — Smithtown, New York

United States Smithtown is a clinical research site located in Smithtown, New York, United States 11787.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

United States Smithtown has participated in 1 clinical trials.

Therapeutic areas: Mesopic Vision, Night Vision Loss.

Sponsors: Ocuphire Pharma, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Smithtown

Browse all research sites in New York · View every site in Smithtown

• Novo Nordisk Investigational Site
• Endocrine Associates of Long Island, PC
• Rheumatology Associates of Long Island
• Research Site
• GSK Investigational Site
• Long Island Skin Cancer and Dermatologic Surgery
• Endocrine Associates of Long Island, P.C.
• Investigational Site Number 840118
• Marina I Peredo, M.D, P.C.
• Investigator Site 114
• Endocrine Assc Long Island PC /ID# 170425
• North Shore Surgi-Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States Smithtown?

United States Smithtown has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States Smithtown conducted?

United States Smithtown has 1 clinical trials on record. Their work covers Mesopic Vision, Night Vision Loss.

Is United States Smithtown accredited by Crixeo Clinical Trials?

United States Smithtown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States Smithtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.